We then discuss emerging data on the role of inter-relationship among macrophage migration inhibitory factor, prostaglandin E2, and estrogen receptor-beta, and the potential utility of targeting these factors in endometriosis treatment. The gene discussed is MIF; the disease is endometriosis.